Adenocarcinoma Of Esophagus Not Yet Recruiting Phase 2 Trials for Rosiglitazone (DB00412)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

IndicationStatusPhase
DBCOND0067383 (Adenocarcinoma Of Esophagus)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04114136Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesTreatment